Improvements in health status and utility associated with ataluren for the treatment of nonsense mutation Duchenne muscular dystrophy.
Erik LandfeldtChristopher LindbergThomas SejersenPublished in: Muscle & nerve (2020)
The outcomes of this study support the association of ataluren for the treatment of nmDMD with improved health status and utility.